Related Experiment Video
Updated: Sep 10, 2025
11:11
Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
Published on: August 24, 2017
16.9K
RARE-seq: an inflection point in cfRNA liquid biopsy
Jonathan C M Wan1, Ahmed Eldarwi2, Luis A Diaz3
1The Francis Crick Institute, 1 Midland Road, London, UK; University College London Hospital, Euston Road, London, UK.
Trends in Pharmacological Sciences
|August 23, 2025
Summary
Researchers developed RARE-seq, a novel method to reduce background noise in cell-free RNA (cfRNA) analysis. This breakthrough enhances the potential of cfRNA liquid biopsies for cancer detection and monitoring.
Area of Science:
- Biomolecular analysis
- Genomics
- Oncology
Background:
- Clinical application of cell-free RNA (cfRNA) liquid biopsies is hindered by significant background noise.
- Existing methods lack the sensitivity for robust transcriptomic profiling and early cancer detection.
Purpose of the Study:
- To develop a denoising method for cfRNA analysis.
- To create a versatile liquid biopsy platform for transcriptomic profiling.
- To improve cancer detection and monitoring using cfRNA.
Main Methods:
- Development of a novel cfRNA analysis technique, termed RARE-seq.
- Implementation of denoising algorithms to reduce background noise in cfRNA data.
- Validation of the platform for transcriptomic profiling and cancer biomarker identification.
Main Results:
- RARE-seq effectively reduces background noise in cfRNA liquid biopsies.
- The platform enables sensitive transcriptomic profiling from cfRNA.
- Demonstrated potential for accurate cancer detection and monitoring.
Conclusions:
- RARE-seq is a versatile liquid biopsy platform that overcomes previous limitations in cfRNA analysis.
- This method unlocks the potential of cfRNA for clinical applications in oncology.
- RARE-seq facilitates advanced transcriptomic profiling for improved cancer diagnostics.
